50 employees
Aperion Biologics is a clinical-stage medical device company developing a technique to make animal-tissues usable for human applications.
2018
$12M
from 3 investors over 3 rounds
Aperion Biologics raised $944K on February 13, 2013
Investors: Hasso Plattner Ventures
Aperion Biologics raised $12M on June 24, 2008
Investors: Hasso Plattner Ventures and Deutsche Bank